These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32464173)
1. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling. Lee C; Willerth SM; Nygaard HB Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173 [TBL] [Abstract][Full Text] [Related]
2. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease. Marei HE; Khan MUA; Hasan A Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028 [TBL] [Abstract][Full Text] [Related]
3. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases. Tcw J Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408 [TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. Yang J; Li S; He XB; Cheng C; Le W Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028 [TBL] [Abstract][Full Text] [Related]
6. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease. Riemens RJM; Kenis G; van den Beucken T Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028 [TBL] [Abstract][Full Text] [Related]
7. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases. Machairaki V Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463 [TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079 [TBL] [Abstract][Full Text] [Related]
10. Patient-derived iPSCs, a reliable Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785 [TBL] [Abstract][Full Text] [Related]
11. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F). Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003 [TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling. Nair M; Sandhu SS; Sharma AK Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763 [TBL] [Abstract][Full Text] [Related]
20. Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer's Disease: The Human Brain Outside the Dish. Tong G; Izquierdo P; Raashid RA Open Neurol J; 2017; 11():27-38. PubMed ID: 29151989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]